ArticleCureus2025
Penile Metastasis From Prostatic Adenocarcinoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Penile metastasis from prostate adenocarcinoma: A case report and review of the literature.SAGE open medical case reports · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Penile metastasis is a rare occurrence, particularly when it presents as the first clinical manifestation of an underlying malignancy. Most cases of penile metastasis arise from genitourinary cancers, particularly prostate and bladder carcinomas. This report discusses the case of a 68-year-old male patient who presented with hematuria and penile pain, accompanied by penile induration and tenderness on palpation during physical examination. Magnetic resonance imaging (MRI) revealed a locally aggressive prostatic tumor, confirmed as adenocarcinoma on biopsy, along with multiple nodular lesions in the corpus spongiosum and corpora cavernosa of the penis, exhibiting intermediate T2 signal intensity, heterogeneous enhancement on contrast-enhanced imaging, and significant diffusion restriction. These findings were strongly suggestive of penile metastasis in the context of disseminated prostate cancer, and the patient was managed with palliative hormone therapy and radiation to alleviate symptoms. This article highlights the rare presentation of penile metastasis as the initial sign of advanced prostate adenocarcinoma, exploring the clinical challenges associated with its diagnosis and the underlying mechanisms of metastatic spread. Emphasis is placed on the critical role of imaging in detecting penile involvement, which can often be challenging to diagnose through clinical examination alone. Despite its rarity, penile metastasis as the first manifestation of cancer requires early recognition and timely intervention. This report underscores the importance of considering penile metastasis in patients, even in the absence of a prior history of malignancy, and emphasizes the need for a comprehensive approach that includes advanced imaging techniques and palliative care strategies to optimize patient outcomes, which are generally poor in this clinical context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.